Bhatla Anjali, Bartlett Victoria L, Liu Michael, Zheng ZhaoNian, Wadhera Rishi K
Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Johns Hopkins Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
JAMA. 2025 Feb 11;333(6):490-497. doi: 10.1001/jama.2024.23450.
Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of private equity acquisitions of US hospitals on patient care experience.
To evaluate whether the acquisition of hospitals by private equity firms was associated with changes in measures of patient-reported experience compared with matched control hospitals from 2008 through 2019.
DESIGN, SETTINGS, AND PARTICIPANTS: This cohort study identified 73 US hospitals newly acquired by private equity firms and 293 matched control (nonacquired) US hospitals from 2008 through 2019. An event study, difference-in-differences design was used to evaluate changes in patient experiences measures from 3 years before to 3 years after private equity acquisition.
The primary outcomes were 2 global measures of patient-reported care experience from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, which included patients' overall hospital rating and willingness to recommend the hospital. Secondary outcomes included the 7 other HCAHPS measures encompassing clinical process, communication, and environmental measures.
There were 73 private equity-acquired hospitals and 293 matched control hospitals. The percentage of patients rating hospitals as a 9 or 10, on a scale of 0 to 10, decreased at private equity-acquired hospitals (65.0% before acquisition and 65.2% after acquisition) when compared with control hospitals (66.2% to 69.2%) during the postacquisition period relative to the preacquisition period with a difference-in-differences estimate of -2.4 percentage points (95% CI, -3.9 to -0.9). In addition, the percentage of patients who would definitely recommend the hospital also decreased at private equity-acquired hospitals (66.9% before acquisition and 65.5% after acquisition) compared with control hospitals (68.2% to 69.3%) with a difference-in-difference estimate of -2.1 percentage points (95% CI, -3.6 to -0.7). For both of these global measures of patient experience, the difference between private equity-acquired and control hospitals increased over time and was largest in year 3 after acquisition (-5.2 percentage points [95% CI, -8.8 to -1.5] and -4.4 percentage points [95% CI, -8.0 to -0.70] for each measure, respectively). For secondary measures of patient care experience, there was a decrease in patient-reported responsiveness of hospital staff at private equity-acquired hospitals compared with control hospitals (-1.3 percentage points [95% CI, -2.4 to -0.2]), but no differential change across other measures of clinical process, communication, and environment.
Patient care experience worsened after private equity acquisition of hospitals. These findings raise concern about the implications of private equity acquisitions on patient care experience at US hospitals.
在过去十年中,私募股权对医疗保健机构的收购迅速增加。然而,对于美国医院的私募股权收购对患者护理体验的影响却知之甚少。
评估与2008年至2019年相匹配的对照医院相比,私募股权公司收购医院是否与患者报告体验指标的变化相关。
设计、设置和参与者:这项队列研究确定了2008年至2019年期间被私募股权公司新收购的73家美国医院和293家相匹配的对照(未被收购)美国医院。采用事件研究、差异中的差异设计来评估私募股权收购前3年到收购后3年患者体验指标的变化。
主要结果是来自医疗服务提供者和系统消费者评估(HCAHPS)调查的2项患者报告护理体验的总体指标,包括患者对医院的总体评分以及推荐该医院的意愿。次要结果包括HCAHPS的其他7项指标,涵盖临床过程、沟通和环境指标。
有73家私募股权收购的医院和293家相匹配的对照医院。在收购后时期相对于收购前时期,与对照医院(从66.2%至69.2%)相比,私募股权收购的医院将医院评为9分或10分(满分10分)的患者百分比下降(收购前为65.0%,收购后为65.2%),差异中的差异估计为-2.4个百分点(95%置信区间,-3.9至-0.9)。此外,与对照医院(从68.2%至69.3%)相比,私募股权收购的医院中肯定会推荐该医院的患者百分比也下降(收购前为66.9%,收购后为65.5%),差异中的差异估计为-2.1个百分点(95%置信区间,-3.6至-0.7)。对于这两项患者体验的总体指标,私募股权收购的医院与对照医院之间的差异随时间增加,在收购后第3年最大(每项指标分别为-5.2个百分点[95%置信区间,-8.8至-1.5]和-4.4个百分点[95%置信区间,-8.0至-0.70])。对于患者护理体验的次要指标,与对照医院相比,私募股权收购的医院中患者报告的医院工作人员响应性有所下降(-1.3个百分点[95%置信区间,-2.4至-0.2]),但在临床过程、沟通和环境的其他指标方面没有差异变化。
私募股权收购医院后患者护理体验恶化。这些发现引发了对私募股权收购对美国医院患者护理体验影响的担忧。